UCSF CME: 39th Annual Advances in Heart Disease 2022 (CME VIDEOS)

Overview

The “UCSF CME: 39th Annual Advances in Heart Disease 2022 (CME VIDEOS)” course provides participants with the latest, evidence-based updates in cardiology, addressing recent developments that impact daily clinical practice. Delivered by a distinguished faculty from the University of California, San Francisco and renowned experts from across North America, this comprehensive program covers the most current advances and challenges in cardiology, including heart failure, arrhythmias, cardiac surgery, genetics, artificial intelligence, and prevention.

Designed for flexibility and convenience, all sessions are recorded and available for online viewing for 30 days post-course—delivering World-Class Medical Learning — Accessible anytime, anywhere.

Learning Objectives

Upon completion of this course, learners will be able to:

• Deliver optimal management for coronary heart disease, hypertension, lipid disorders, diabetes, systolic and diastolic heart failure, atrial fibrillation and flutter, STEMI, non-STEMI, and thromboembolic disease.
• Refine considerations for atrial fibrillation, atrial flutter, and ventricular tachycardia ablation.
• Apply the latest evidence on surgical revascularization and percutaneous intervention in coronary heart disease management.
• Recognize and implement effective risk stratification for cardiovascular disease.
• Optimize the management of ascending thoracic aorta disease and pulmonary embolism.
• Understand the role of cardiac surgery in treating endocarditis.
• Identify the genetic basis of cardiovascular diseases and incorporate it in practice.
• Appreciate the importance of deep empathy and the mind-heart connection in patient care.
• Address differences in pathophysiology and treatment among diverse racial and ethnic groups.
• Advance the management of cardiac amyloidosis using up-to-date approaches.
• Recognize air pollution as a risk factor in cardiovascular disease.

Topics

• Registration and Continental Breakfast
• Welcome and Symposium Overview
• Session: Frontiers in Cardiology: Genetics, Artificial Intelligence and Deep Empathy
• The Mind-Heart Connection: Stress and Trauma as Cardiovascular Risk Factors
• Artificial Intelligence in Cardiology
• Ascending Thoracic Aortic Aneurysms: Evaluation, Management and Genetic Testing
• Coffee Break
• Update on Transthyretin Amyloidosis
• Gene Targeting for Cardiometabolic Diseases – Where are We?
• Elliot Rapaport Keynote Lecture: High Performance with Deep Empathy Medicine
• Lunch (on Your Own)
• Session: State-of-the-Art: Cardiovascular Interventions
• New Approaches to Pulmonary Embolism
• Physiological Assessment of Coronary Stenosis Severity by CT Angiography and in the Cath Lab
• Expanding Options in the Management of Endocarditis
• Coffee Break
• Surgical Approaches to Advanced Heart Failure
• Revascularization in Stable Coronary Disease: Sorting through the Evidence
• Adjourn
• Continental Breakfast
• Announcements
• Session: Advances and Controversies in Electrophysiology
• Defining Sudden Cardiac Death in 2022
• ECG Findings Suggesting High Arrhythmic Risk
• Debate: AFib Ablation Should be First Line Therapy in Patients with Symptomatic AFib
• Coffee Break
• Advances in Cardiac Imaging for Arrhythmia Etiology, Prognosis and Therapy
• The Effect of Alcohol, Exercise and Lifestyle on Atrial Fibrillation
• Interventions for Novel/Genetic Arrhythmias
• Debate: Prophylactic Primary Prevention ICD in Dilated Cardiomyopathy with Heart Failure
• Lunch (on your own)
• Session: Managing Heart Failure
• Cardiogenic Shock
• New Heart Failure Guidelines for HFrEF
• New Heart Failure Guidelines for HFpEF
• Coffee Break
• Polypharmacy and Medication Costs for Guideline Directed Medical Therapy for HFrEF
• Remote Monitoring of Patients with Cardiovascular Diseases
• Adjourn
• Continental Breakfast
• Announcements
• Session: Managing Cardiovascular Risk
• The Effect of Salt and Salt Substitutes Consumption on Clinical Outcomes in Hypertension and Heart Failure
• Managing Cardiovascular Risk in the Elderly
• Current Cholesterol Guidelines: Controversies and Agreements
• Where Are We with Non-Statin Lipid Modifying Therapy?
• Management of Cardiovascular Risk and Chronic Kidney Disease Progression with Patients with Diabetes
• Impact of Air Pollution on Cardiovascular Outcomes
• Adjourn

Target Audience

This program is tailored for healthcare professionals committed to elevating patient care in cardiology. The course is especially valuable for:

• Cardiovascular specialists
• Practicing cardiologists
• Internists
• Family physicians
• Healthcare professionals involved in cardiovascular care

Speakers

• Peter Ganz, MD
• Priscilla Hsue, MD
• Ahmed Tawakol, MD
• Geoff Tison, MD, MPH
• Lisa Wilsbacher, MD, PhD
• Mandar Aras, MD, PhD
• John Chorba, MD
• Eric Topol, MD
• Lucas Zier, MD, MS
• Gregory Piazza, MD, MS
• William Fearon, MD
• Amy Fiedler, MD, MS
• Ann Bolger, MD
• Jason Smith, MD
• Jeffrey Zimmet, MD, PhD
• Nora Goldschlager, MD
• Zian Tseng, MD, MAS
• Melvin Scheinman, MD
• Adam Lee, MD
• Tommy Dewland, MD
• Edward Gerstenfeld, MD, MS
• Gregory Marcus, MD, MAS
• Vasanth Vedantham, MD, PhD
• Byron Lee, MD, MS
• Joshua Moss, MD, MS
• Jonathan Davis, MD, MPHS
• Jaya Mallidi, MD
• Anusha McNamara, PharmD
• Rose Pavlakos, PharmD
• Liviu Klein, MD, MS
• Binh An P. Phan, MD
• Michael Crawford, MD
• Carlin Long, MD
• Jorge Plutzky, MD
• Lisa Murphy, MD, PhD
• Karol Watson, MD, PhD

Educational content only. Not medical advice.